Expanding the boundaries of nutrition Luis Cantarell

Similar documents
Welcome to the Full -Year Results Press Conference

An exciting combination in a high growth, high margin Nutrition category. Name of chairman

Nestlé Health Science Overview

Nestlé Investor Seminar 2008

Nestlé Dairy s new frontier: healthy ageing

January 30, 2018 Dow Wilson President and Chief Executive Officer

Liquid Biopsies. Next Generation Cancer Molecular Diagnostics

Nutrition, Health & Wellness The Nestlé Perspective. Paul Bulcke Chief Executive

Putting ALK on the right growth trajectory

LEERINK GLOBAL HEALTHCARE CONFERENCE. Marino Garcia EVP, Chief Strategy Officer February 15, 2017

MedSurg: Endoscopy Presentation for the Investment Community at DDW. Art Butcher Senior Vice President and President, Endoscopy

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

Nestlé Investor Seminar 2007

Company presentation. SEB Nordic Seminar Bella Sky, Copenhagen. Carsten Hellmann, President & CEO 9 January 2018

Championing patients every step of the way

Slide 1. Welcome and strategy update. Lars Fruergaard Jørgensen President and CEO

Consumer Care A Strong Foundation in Consumer Health

Patrick J. Sullivan Chief Executive Officer. January 9, 2018 Investor Presentation

Patrick J. Sullivan, President & CEO March 7, 2016 Raymond James 37 th Annual Institutional Conference

Photocure ASA Executing the Strategy

Credit Suisse 27 th Annual Healthcare Conference

Genomic Health. Kim Popovits, Chairman, CEO and President

Intercell and Novartis form world leading strategic partnership to drive vaccines innovation

PHOTOCURE COMPANY PRESENTATION. March 2018

Positioned for Growth

Oragenics Shareholder Update

A world leader in allergy immunotherapy

Photocure ASA Executing the Strategy

Delivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental

Human Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS

Welcome to the Nine-Month Sales Conference

Purolite Life Sciences Brand Positioning Catalyst

2018 Corporate Partnership Opportunities

For personal use only

Innovation from the Foundation Sonya Dumanis, PhD

Epilepsy Foundation North/ Central Illinois. FY19-FY21 3 year Strategic Plan 20 June 2018

JP Morgan Healthcare Conference

Nordea investor meeting. June 18 th, 2018 Kristian Villumsen, EVP Chronic Care

J.P. Morgan Healthcare Conference

DuPont Nutrition & Health Craig Binetti, President

Carers Australia Strategic Plan

AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance. Becoming Global Leaders In Diabetes

The New Medtech Economic Reality MassMEDIC Annual Meeting

FAMILY & CHILDREN S SERVICES STRATEGIC PLAN

Myriad Genetics Corporate Presentation 06/13/2018

Myriad Genetics Corporate Presentation 6/4/13

QiG INS Conference May 22, 2011

Visionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics

Merck Announces FDA Approval of KEYTRUDA. Provided to Investors as a Reference

Opportunities and Challenges in the Development of Companion Diagnostics

Vision. Mission. Hopelink s Values. Introduction. A community free of poverty

Michael L. Levitz Chief Financial Officer. November 15, 2017 Investor Presentation

Slide 1. Welcome and introduction. Lars Rebien Sørensen President & CEO

2015 Investor Conference

Another Record Year for Bayer HealthCare Pharmaceuticals in Asia Pacific

AVEO Oncology Announces Strategic Restructuring. AVEO to Host Conference Call Wednesday, June 5 at 8:30 a.m. ET

N a s d a q : I N S Y

Roche Diagnostics Daniel O Day COO Roche Diagnostics. Société Générale - The Premium Review Conference, Paris December 2, 2011

Valneva Reports Strong 2017 Revenues Driven by Double Digit Product Sales Growth

Media Contact: Ron Rogers Investor Contact: Scott Gleason (801) (801)

Jefferies Healthcare Conference

Merrill Lynch Healthcare Conference New York

H. LUNDBECK A/S. Teleconference. 10 August PM CET. Financial results Second quarter 2011

Investor Day LA&C Region Lausanne, September 29, Jeanne Pollès President, Latin America & Canada Region

Developing & Commercializing Targeted Small Molecule Drugs in Cancer

Annual Shareholders Meeting

UNMC Nebraska Medicine Strategic Plan

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO

Food Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS

37 th ANNUAL JP MORGAN HEALTHCARE CONFERENCE

Slide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes

August 7, Q Financial Results

Health Science in the NHS:

Novartis announces Phase III STRIVE data published in NEJM demonstrating significant and sustained efficacy of erenumab in migraine prevention

Shaping the Future. Nestlé Research World-Wide. Werner Bauer. Chief Technology Officer

Myriad Genetics Fiscal First-Quarter 2017 Earnings Call 11/01/2016

Two-stage study designed to evaluate tolerability and efficacy of pracinostat combined with azacitidine in patients with high and very high risk MDS

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE

The value of integrated reporting

A world leader in allergy immunotherapy. Jefferies Global Healthcare Conference, London : 19 November 2014 : Flemming Pedersen, CFO & EVP

Corporate Presentation

Innovator Case Studies: Oncology Networks

YMCA Calgary. Strategic Plan

The Global Network Aiming to deliver safe quality care in relation to tobacco for every service user, every time and everywhere

Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO

Partnering for Growth

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Chronic Care Coloplast Meet the Management London 2017 Kristian Villumsen, EVP Chronic Care Edmond Veome, SVP Chronic Care North America

Cochlear Limited 2017 Annual General Meeting Chairman s Address

2018 Bank of America Merrill Lynch Healthcare Conference

STRATEGIC PLAN

JP Morgan Healthcare Conference

Welcome to the New York Press Conference

Jeff Balser, M.D., Ph.D., President and CEO of Vanderbilt University Medical Center, and Dean, Vanderbilt University School of Medicine.

VeriStrat Poor Patients Show Encouraging Overall Survival and Progression Free Survival Signal; Confirmatory Phase 2 Study Planned by Year-End

34 th Annual J.P. Morgan Healthcare Conference

Eli Lilly and Company Tailored Therapeutics and Diagnostics

Personalized medecine Biomarker

Coca-Cola Wellness Toolkit: Healthcare

Transcription:

Expanding the boundaries of nutrition Luis Cantarell Nestlé Investor Seminar 30 September 2013

Disclaimer This presentation contains forward looking statements which reflect Management s current views and estimates. The forward looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those contained in the forward looking statements. Potential risks and uncertainties include such factors as general economic conditions, foreign exchange fluctuations, competitive product and pricing pressures and regulatory developments.

Expanding the boundaries of nutrition What does it mean? Survival Secured supply Taste / variety Health & wellness Prevention, treatment, disease management Food supply Food security Food pleasure Health prevention Health science Page 3

Nestlé world leader in Nutrition, Health & Wellness Enhancing the quality of life with good food & beverages everywhere with nutritional solutions for disease management Page 4

Macroeconomic & socio-demographic trends The New Reality Ageing population Rising chronic disease epidemics 1900 1950 2000 2050 Diabetes Cardiovascular. Alzheimer s Osteoporosis Stroke Scientific evolution Healthcare costs keep rising Page 5

Elevating the role of nutrition The potential of nutrition is real Creating a value message for payers on cost effectiveness Educating our stakeholders on the role of nutrition to achieve better outcomes Building the evidence through clinical and health economics data Page 6

We have assembled a strong team NHSc leadership team diverse experience Luis Cantarell President & CEO Dan Stroud Chief Financial Officer Michel Gardet Global Business Head HCN Cathy Kerzner Head of Strategy & Marketing Claudio Kuoni General Counsel Irène Corthésy Head of R&D Jean-Christophe Font Head of Human Resources Bruce McConnell Head of Business Development Thierry Trouvet Head of Operations Jean Zetlaoui Chief Medical Officer Marie-Françoise Rütimeyer Head of Communications Page 7

We have defined our territory Ageing Medical Care Critical Care / Surgery Paediatric Medical Care Brain Health Medical Devices Diagnostics + Monitoring Metabolic Health Gastrointestinal Health Page 8

HealthCare Nutrition business Strong and growing Sales: accelerated CAGR OG of 7.2% (2010-2012) Ranking: #1 or #2 in 11 of top 16 markets Industrial investment driving competitive advantage and operational efficiency Vitaflo: high double-digit growth and ongoing geographical expansion Page 9

and we are continuing to innovate Convenience and taste Unique technologies in tube feeding packaging Enteral nutrition connectors enhancing patient safety Differentiated disease specific solutions Page 10

Developing and building capabilities Acquisitions, partnerships, investments 2011 * 2012 Diagnostics (Dx) core capability Gastrointestinal and oncology products (Rx) Neurological disorders (e.g. Alzheimer s Disease) 2013 ** * Minority interest 2013 Chronic metabolic and neurologic conditions Gastrointestinal disorders Traditional Chinese medicine library ** JV Page 11

Nestlé Institute of Health Sciences innovation Leading at the new frontiers Situated within the EPFL campus linked to innovation network Laboratories: 15 Scientific recognition: 43 publ. and 3 grants (2012/13) Employees: 110 63% Ph.D. 19 nationalities Diverse backgrounds: FDA, Novartis, BASF, NHSc_IR_Sept2013 Apple,

NIHS Mission, strategic direction and deliverables Metabolic health Brain health Gastrointestinal health Ageing medical care Critical care & surgery Paediatric medical care Competence areas Systems & computation science Molecular signalling & biomarkers Mitochondria, cellular models Micronutrients, microbiome analysis Natural products screening Page 13

The Impact story Immunonutrition in the management of disease Disease / patient need Nutritional solution Clinically proven High complication rate after elective GI cancer surgery: 31% Postoperative complications lead to prolonged hospitalisation & increased costs IMPACT Immunonutrition More than 2,500 patients undergoing surgery for GI malignancies Clinical trials: 28 Immunonutrition reduces risk of post-operative infections: -36% length of hospital stay: -2.6 days Cost savings per patient CHF2,600 Page 14

The Meritene story Nutritional Supplements for adults / kids Disease / patient need Nutritional solution Clinically proven For kids and adults requiring special nutritional support due to: Lack of appetite Picky eaters Illness Ageing Convalescence Clinical evidence supporting oral nutritional supplements Level A of evidence in most clinical situations Recognised in peer publications (i.e. Lancet) Page 15

The PKU Story For inborn metabolic disorders Disease / patient need Nutritional solution Clinically proven Inborn error of metabolism Nutritional therapy is the gold standard Vitaflo s portfolio offers diet for life solutions Two siblings with PKU. Only the sister had been diagnosed and treated since birth Page 16

Our unique innovation model Utilising the innovation network Dx = Diagnostics, prognosis & monitoring Dx Science-based, targeted nutritional solutions to protect health & manage chronic diseases Rx = Drug treatment Rx Nx Nx = Nutrition Page 17

It starts with the patient The Patient Journey GI Example Unmet needs Longer remission periods Patient empowerment Opportunities Nutritional solutions Page 18 Page 18

Prometheus diagnostic technology innovation Personalising patient care Launch 2012 Greater clarity in understanding loss of response Launch 2013 Backed by clinical evidence Two new diagnostic launches covering the most broadly used biologic treatments for IBD (Inflammatory Bowel Disease) Reports help inform GI specialists in their patient management decisions Page 19

10 years to become leader Building a transformational business NHSc Start We are executing on our strategy 2 years to build leading organisation Innovation network Portfolio investments 5 years to build product portfolio & pipeline In-house new products Innovation network Portfolio investments 10 years to become leader HealthCare Nutrition HealthCare Nutrition HealthCare Nutrition Page 20

A forward looking vision An innovative approach A coherent, phased strategy A winning team! Delivering good results today and ready for the future Page 21